Literature DB >> 8104320

Steroid hormones protect spinal cord neurons from glutamate toxicity.

T Ogata1, Y Nakamura, K Tsuji, T Shibata, K Kataoka.   

Abstract

The effects of steroid hormones on glutamate neurotoxicity were examined in cultured spinal cord neurons. The extent of neuronal damage, produced by glutamate exposure for 15 min, was estimated based on the activity of lactate dehydrogenase released from degenerated neurons to the media during 24 h of post-exposure incubation. This damage was dependent on the glutamate concentrations used. The addition of dexamethasone, a synthetic steroid, in post-exposure media remarkably reduced the extent of damage in a dose-dependent manner. The half effective concentration for the steroid was approximately 0.7 microM, which was in the range of pharmacological concentration. Dexamethasone was effective even when it was added 2 h after glutamate exposure. Some endogenous steroid hormones--aldosterone, progesterone and testosterone--also showed similar neuroprotective effects. However, cholesterol, a precursor of these steroid hormones, had no effect on glutamate neurotoxicity. This direct protective effect on neurons against glutamate neurotoxicity may explain, at least partly, the mechanisms of beneficial effects of steroid hormones on in vivo spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104320     DOI: 10.1016/0306-4522(93)90513-f

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  19 in total

Review 1.  Multifunctional drugs for head injury.

Authors:  Robert Vink; Alan J Nimmo
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

Review 2.  Estrogen and testosterone therapies in multiple sclerosis.

Authors:  Stefan M Gold; Rhonda R Voskuhl
Journal:  Prog Brain Res       Date:  2009       Impact factor: 2.453

3.  Progesterone treatment normalizes the levels of cell proliferation and cell death in the dentate gyrus of the hippocampus after traumatic brain injury.

Authors:  Cindy K Barha; Tauheed Ishrat; Jonathan R Epp; Liisa A M Galea; Donald G Stein
Journal:  Exp Neurol       Date:  2011-06-13       Impact factor: 5.330

4.  Mineralocorticoids: the secret of muscle reflex dysfunction in hypertension?

Authors:  Han-Jun Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-08-19       Impact factor: 4.733

Review 5.  Progesterone inhibition of neuronal calcium signaling underlies aspects of progesterone-mediated neuroprotection.

Authors:  Jessie I Luoma; Christopher M Stern; Paul G Mermelstein
Journal:  J Steroid Biochem Mol Biol       Date:  2011-11-12       Impact factor: 4.292

6.  Progesterone treatment in two rat models of ocular ischemia.

Authors:  Rachael S Allen; Timothy W Olsen; Iqbal Sayeed; Heather A Cale; Katherine C Morrison; Yuliya Oumarbaeva; Irina Lucaciu; Jeffrey H Boatright; Machelle T Pardue; Donald G Stein
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

7.  Supraspinal respiratory plasticity following acute cervical spinal cord injury.

Authors:  Tatiana Bezdudnaya; Vitaliy Marchenko; Lyandysha V Zholudeva; Victoria M Spruance; Michael A Lane
Journal:  Exp Neurol       Date:  2017-04-19       Impact factor: 5.330

8.  Effect of endogenous androgens on 17beta-estradiol-mediated protection after spinal cord injury in male rats.

Authors:  Supatra Kachadroka; Alicia M Hall; Tracy L Niedzielko; Sukumal Chongthammakun; Candace L Floyd
Journal:  J Neurotrauma       Date:  2010-03       Impact factor: 5.269

Review 9.  Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease.

Authors:  Milos Cekic; Iqbal Sayeed; Donald G Stein
Journal:  Front Neuroendocrinol       Date:  2009-04-24       Impact factor: 8.606

10.  Estradiol attenuates spinal cord injury-related central pain by decreasing glutamate levels in thalamic VPL nucleus in male rats.

Authors:  Asieh Naderi; Ali Reza Asgari; Reza Zahed; Ali Ghanbari; Razieh Samandari; Masoumeh Jorjani
Journal:  Metab Brain Dis       Date:  2014-05-31       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.